A shipment of 1.13 million doses of the Moderna COVID-19 vaccine is due to arrive in Taiwan early today, while the next round of Pfizer-BioNTech vaccines to be administered under a national program has been expanded to include people aged 45 or older.
Deputy Minister of the Interior Chen Tsung-yen (陳宗彥), the Central Epidemic Command Center’s (CECC) deputy head, said that the Moderna vaccines purchased directly from the manufacturer were slated to arrive at Taiwan Taoyuan International Airport from Atlanta, Georgia, between last night and early this morning.
The doses would be reserved primarily as second shots for people who received their first jab of the Moderna vaccine on or before July 16, the CECC said.
Photo: Chu Pei-hsiung, Taipei Times
Taiwan also took delivery of a seventh shipment of 889,200 doses of the Pfizer-BioNTech COVID-19 vaccine early yesterday morning, Chen told the CECC’s daily news briefing.
The BioNTech shipment arrived at the airport from Germany as part of a combined 15 million doses ordered separately by the Hon Hai Precision Co-affilaited Yonglin Foundation, Taiwan Semiconductor Manufacturing Co and the Buddhist Compassion Relief Tzu Chi Foundation to be donated to the government for public distribution.
With yesterday’s shipment, Taiwan has now received about 5.09 million of the 15 million doses, the CECC said.
Eligibility for the upcoming round of Pfizer-BioNTech vaccines will be lowered to include people aged 45 and older, from the previously intended target of 47 and older announced by the CECC on Monday, Chen said.
People wishing to receive their first shot of this brand can make online appointments next week from 10am on Monday to midday on Wednesday, he said.
Also included in this round is the AstraZeneca vaccine, targeting second shots for people aged 18 or older who had a first AstraZeneca jab on or before July 22, he said.
Second AstraZeneca jabs will also be available to those aged 54 or older who had their first AstraZeneca dose on or before July 30, Chen added.
Alain Robert, known as the "French Spider-Man," praised Alex Honnold as exceptionally well-prepared after the US climber completed a free solo ascent of Taipei 101 yesterday. Robert said Honnold's ascent of the 508m-tall skyscraper in just more than one-and-a-half hours without using safety ropes or equipment was a remarkable achievement. "This is my life," he said in an interview conducted in French, adding that he liked the feeling of being "on the edge of danger." The 63-year-old Frenchman climbed Taipei 101 using ropes in December 2004, taking about four hours to reach the top. On a one-to-10 scale of difficulty, Robert said Taipei 101
Nipah virus infection is to be officially listed as a category 5 notifiable infectious disease in Taiwan in March, while clinical treatment guidelines are being formulated, the Centers for Disease Control (CDC) said yesterday. With Nipah infections being reported in other countries and considering its relatively high fatality rate, the centers on Jan. 16 announced that it would be listed as a notifiable infectious disease to bolster the nation’s systematic early warning system and increase public awareness, the CDC said. Bangladesh reported four fatal cases last year in separate districts, with three linked to raw date palm sap consumption, CDC Epidemic Intelligence
US climber Alex Honnold left Taiwan this morning a day after completing a free-solo ascent of Taipei 101, a feat that drew cheers from onlookers and gained widespread international attention. Honnold yesterday scaled the 101-story skyscraper without a rope or safety harness. The climb — the highest urban free-solo ascent ever attempted — took just more than 90 minutes and was streamed live on Netflix. It was covered by major international news outlets including CNN, the New York Times, the Guardian and the Wall Street Journal. As Honnold prepared to leave Taiwan today, he attracted a crowd when he and his wife, Sanni,
Taiwanese and US defense groups are collaborating to introduce deployable, semi-autonomous manufacturing systems for drones and components in a boost to the nation’s supply chain resilience. Taiwan’s G-Tech Optroelectronics Corp subsidiary GTOC and the US’ Aerkomm Inc on Friday announced an agreement with fellow US-based Firestorm Lab to adopt the latter’s xCell, a technology featuring 3D printers fitted in 6.1m container units. The systems enable aerial platforms and parts to be produced in high volumes from dispersed nodes capable of rapid redeployment, to minimize the risk of enemy strikes and to meet field requirements, they said. Firestorm chief technology officer Ian Muceus said
RSS